The Chicago White Sox have secured a new agreement with pitcher Mike Clevinger, reinforcing their roster for the 2024 season. In a move aimed at bolstering their pitching lineup, the team finalized a contract that will see Clevinger in a White Sox uniform for an additional season. Under this contract, Clevinger will receive $3 million for the upcoming season, with the potential to earn an extra $3 million in performance-based incentives. This agreement, however, is contingent upon the pitcher passing a physical examination.
Clevinger's Journey and Challenges
Moving to the South Side of Chicago last winter on a one-year, $12 million deal, Clevinger’s tenure with the White Sox came amid certain challenges. Notably, the pitcher was under investigation for allegations of domestic violence, though these did not result in any formal sanctions. Over the course of the season, Clevinger delivered a steady performance, recording a 3.77 ERA across 131 1/3 innings pitched.
However, consistency was hindered by health issues, as Clevinger found himself on the injured list twice throughout the year. Adding to his adversities, he underwent Tommy John surgery in November 2020, a significant procedure that can influence a pitcher’s road to recovery and return to peak performance. Statistical analyses from last season indicate a dip in Clevinger’s strikeout rate to 20%, falling below the league average. This decline could partially be attributed to the inherent challenges of regaining form post-surgery and managing injuries.
Despite an ERA that paints a relatively positive picture, advanced metrics tell a more nuanced story of Clevinger’s performance. With a 4.28 Fielding Independent Pitching (FIP) and a 4.81 Skill-Interactive Earned Run Average (SIERA), there’s indication that he might have encountered more struggles than surface-level statistics suggest. These figures, alongside a .281 batting average on balls in play (BABIP) and a 77.2% strand rate, hint at factors of fortune and defensive support playing roles in his overall performance.
Looking Ahead: The White Sox's Strategy for 2024
As the White Sox gear up for the 2024 season, adjusting their pitching staff is a key focus. Clevinger is set to be a crucial part of the rotation, provided he can navigate the challenges presented by his recent surgery and health record. Considering the depth and potential changes within the team’s pitching roster, some current starters might be explored as trade possibilities. This strategy indicates a willingness by the White Sox to refresh their approach and seek optimized performance from their pitchers.
Clevinger, for his part, remains committed to refining his pitching mechanics and enhancing his strikeout rate. These improvements are pivotal not only for his personal success but also for the White Sox's collective aim to strengthen their rotation. The decision to re-sign Clevinger reflects a belief in his underlying talent and potential for rebound, signaling the organization’s confidence that he can overcome the hurdles of the past seasons.
As Mike Clevinger and the Chicago White Sox set their sights on the 2024 season, both parties are brimming with optimism. Despite the ups and downs, Clevinger’s continued journey with the team represents a mutual commitment to excellence and a shared vision for success. With time and dedicated effort, there’s hope within the organization that Clevinger will not only return to his pre-surgery form but also emerge as a key contributor to the White Sox’s aspirations in the major leagues.